Biopharmaceutical Analysis

An expansion of laboratory facilities in Geneva, Switzerland expands SGS services for high-order structure analysis.

The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.

More complex biologic samples must be evaluated to ever higher levels of specificity and sensitivity.

Materials in contact with a drug must be fully characterized to ensure they do not negatively affect the safety and efficacy of the product.

FDA and ICH seek comment on new exposure levels for cadmium in drug products.

Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science.

Process analytical technology tools have enabled manufacturers to monitor and control their production processes.

This article discusses affinity capture for tier determination and surveys a broad collection of commonly and less commonly used assays to analyze cell culture media

Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.

The National Institute of Standards and Technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pathlength standard for UV absorbance measurements for use with the new generation of microvolume spectrophotometers and short-pathlength cuvettes.

Process understanding and careful assessment of risks are essential in developing viral clearance programs.

Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.

The company’s investment in new laboratory equipment and personnel will strengthen its cell line development services.

The company showcased newer products and equipment for cell culture laboratories at Analytica 2018 in Munich, Germany.

The new platform is expected to speed up cell line development.

A new scientific publication examines analytical processes for the emerging legal cannabis industry.

RGtimeline/Shutterstock.comParenteral product quality is improving.

Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.

The Concentrating Pipette Select from InnovaPrep is a small automated benchtop instrument that can concentrate contaminates from large volumes of liquids for improved detection.

Outsourcing analytics can be a cost-effective way for biopharma companies to adapt to new technologies and regulations.

The company’s close communication with customers has enabled it to bring advanced pipetting products to market.

The company’s Krios G3i cryo-electron microscope is a finalist in the 2018 Edison Awards.

Gyros Protein Technologies’ new immunoassay technology includes expanded software to optimize time to results and sample capacity while simplifying workflows.

Telstar reports that its Boreas, a new 86° ultra-low-temperature freezer, increases average performance by 20%.

Contract testing organizations can provide bio/pharma companies with a cost-effective way to adapt to new technologies and regulations.